Public Engagement

See our upcoming events


Jenner Institute




Vaccines Manufacturing Innovation Centre application led by Jenner Institute awarded £66 million

Posted 03/12/2018

An application led by the Jenner Institute for a new Vaccines Manufacturing Innovation Centre  has been awarded £66 million through the UK government’s Industrial Strategy Challenge Fund (ISCF). The UK’s first-ever dedicated Vaccines Manufacturing Innovation Centre will create cost-effective ways of developing and manufacturing vaccines for global distribution, as well as ensuring the UK’s preparedness in the event of pandemics of infectious diseases such as Ebola and Lassa. The centre is expected to open in 2022, with the first products from the centre expected later that year. The centre will be built in Oxford, creating more than 50 jobs in the local area. 

Congratulations to Jenner Institute's new Professor and Associate Professors

Posted 09/08/2018

The Medical Sciences Divisional Panel has conferred the title of Professor on Associate Professor Simon Draper and the title of Associate Professor on Dr Teresa Lambe, Dr George Warimwe and Dr David Wyllie. They have all been awarded these titles in recognition of their distinction in their respective fields and contributions to the research, teaching and administration of the Department and we congratulate them on their success.

News Archive

Recent Publications

Current approaches towards identifying a correlate of immune protection from tuberculosis. Expert Rev Vaccines, pp. 1-17. Article

Prevention of enteric fever in travellers with typhoid conjugate vaccines. J Travel Med. Article

Clinical Trials

Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.

If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.

Jenner Institute Podcasts

See all Jenner podcasts


Dr Richard Hatchett, CEO: Can we end epidemics? - NOW STARTING 9.15AM, 17/Dec/2018 09:15

Prof Marshall Lightowlers: Controlling two helminth infections, cysticercosis and echinococcosis, using highly effective recombinant antigen vaccines, 11/Jan/2019 11:00

All Seminars